The FERTILE Study: Evaluating ovarian toxicity Outcomes Following Immunotherapy in Triple-Negative Breast Cancer (TNBC)
Description: Immunotherapy causes substantial damage to ovaries in mice. It is not known if immunotherapy can cause similar damage to human ovaries, leading to infertility and early-onset menopause. less thanbrgreater thanless thanbrgreater thanThis is a crucial information gap for patients. less thanbrgreater thanless thanbrgreater thanThis study will assess ovarian function in premenopausal women with early-stage, curable triple negative breast cancer receiving chemoimmunotherapy, and will provide the first prospective human data on the impact of chemoimmunotherapy on ovarian function.
Amount: A$652,500
Funding type: research
Funder scheme: Medical Research Future Fund
Start date: 2025-06-01
End date: 2028-09-30
Institutions: The University of Melbourne, University of Melbourne
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Funded outputs count: 0
Funder award ID: GA480230
OpenAlex ID: G1490134109
